Company intelligence / Profile preview

OptiPEA

Nijmegen, Gelderland, Netherlands
Ownership
Private
Development stage
Other
01

Overview

Innexus Nutraceuticals is a Dutch biotechnology company specializing in the development and supply of high-quality nutraceutical ingredients, most notably its flagship product, OptiPEA. OptiPEA is a premium, GMP-certified brand of palmitoylethanolamide (PEA), a naturally occurring bioactive lipid known for its anti-inflammatory and analgesic properties. The company utilizes a patented production process in the Netherlands to ensure the purity and sustainability of its PEA, which is sourced from RSPO-certified palmitic acid. Innexus positions OptiPEA as a safe, science-backed alternative to CBD and opioids for managing chronic pain and inflammation. Their products are used globally by supplement manufacturers and researchers in the fields of neurology and pain management. The company is recognized as the only European manufacturer of PEA produced under pharmaceutical-grade GMP conditions.

Therapeutic areas
ImmunologyNeurology
Modalities
Small molecule
Industry
Food & Nutrition
02

Partnerships

IMCD

Beyond the preview

Go deeper on OptiPEA.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on OptiPEA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call